Cleared Traditional

CONTROL SYRINGE (K972655) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K972655 · Medical Specialties Intl., Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1997
Decision
112d
Days
Class 2
Risk

K972655 is an FDA 510(k) clearance for the CONTROL SYRINGE. Classified as System, X-ray, Angiographic (product code IZI), Class II - Special Controls.

Submitted by Medical Specialties Intl., Inc. (Tarpon Springs, US). The FDA issued a Cleared decision on November 4, 1997 after a review of 112 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1600 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Medical Specialties Intl., Inc. devices

Submission Details

510(k) Number K972655 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 15, 1997
Decision Date November 04, 1997
Days to Decision 112 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
5d slower than avg
Panel avg: 107d · This submission: 112d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code IZI System, X-ray, Angiographic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1600
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IZI System, X-ray, Angiographic

All 46
Devices cleared under the same product code (IZI) and FDA review panel - the closest regulatory comparables to K972655.
ARTIS ZEE AND ZEEGO
K073290 · Siemens Medical Solutions USA, Inc. · Feb 2008
DIGITAL IMAGING SYSTEM (BSR)
K991922 · Siemens Medical Solutions USA, Inc. · Sep 1999
ADVANTX LCN, ADVANTX LCLP
K974367 · GE Medical Systems · Feb 1998
ADVANTX LCV+
K960575 · GE Medical Systems · May 1996
ADVANTX LCA
K945375 · GE Medical Systems · Jan 1995
DLX
K945459 · General Electric Co. · Jan 1995